WASHINGTON — In order to create guidelines for digital therapeutics, consistent and validated evidence must be presented, according to a panel at the Digital Therapeutics Alliance Summit.Currently, speakers said, the assessments for digital therapeutics vary, which has led to a range of ways to create guidelines.
WASHINGTON — Once a meeting with Congress is established, there are some things to keep in mind to successfully advance digital health policy, according to a panel at the Digital Therapeutics Alliance Summit.“In a divided Congress. you have to get creative,” said Vic Goetz, health policy adviser to U.S. Sen. Jeanne Shaheen (D-NH).
As the patient-to-medical staff ratio narrows partially due to demand for medical services and current staffing shortages, clinicians are looking for new ways to assess conditions and develop treatment options.Digital therapeutics (DTx) could be one answer, representatives of Digital Therapeutic Alliance (DTA) told Healio.
The market for digital therapeutics products is expected to grow given increasing global access to smart technologies, their cost-effectiveness, and the need for patient-specific treatments.